(Q39662490)

English

Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction

scientific article published on July 17, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

3

object named as

A. Vuletić

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800424

3 July 2024

author name string

G. Konjević

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800424

3 July 2024

K. Mirjačić Martinović

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800424

3 July 2024

S. Radenković

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800424

3 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20800424

3 July 2024

publication date

17 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0753332210001265?httpAccept=text/xml

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

https://api.elsevier.com/content/article/PII:S0753332210001265?httpAccept=text/plain

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Biomedicine and Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

663-671

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

1

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Biology of natural killer cells

2

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Analysis of perforin expression in human peripheral blood lymphocytes, CD56+ natural killer cell subsets and its induction by interleukin-2.

4

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

The biology of human natural killer-cell subsets

5

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity

6

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity

10

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Natural killer cell receptor signaling

11

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Human natural killer cell development and biology

12

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Roles of the NKG2D immunoreceptor and its ligands

13

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

The role of the activating receptor NKG2D in autoimmunity

14

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions

15

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity

16

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

17

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Natural killer cell developmental pathways: a question of balance.

19

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor

20

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor

21

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Human diversity in killer cell inhibitory receptor genes

22

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Mini-review: defense strategies and immunity-related genes

23

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

24

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

25

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

The Yin and Yang of HLA and KIR in human disease

26

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Expression of killer immunoglobulin-like receptors on peripheral blood NK cell subsets of women with recurrent spontaneous abortions or implantation failures.

27

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Type I IFN contributes to NK cell homeostasis, activation, and antitumor function

28

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma

29

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Immunology and immunotherapy of human cancer: present concepts and clinical developments

30

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway

31

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Distinct requirements for IFNs and STAT1 in NK cell function

32

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

33

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes

34

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Proceedings of the National Academy of Sciences of the United States of America

35

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Emerging targets of biologic therapies for rheumatoid arthritis

36

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.

38

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

39

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

40

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts

41

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

42

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Immunophenotypic Characterization of Normal Blood CD56+lo Versus CD56+hi NK-Cell Subsets and Its Impact on the Understanding of Their Tissue Distribution and Functional Properties☆

43

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.

44

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.

45

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

The proliferation and function of human mononuclear leukocytes and natural killer cells in serum-free medium

47

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings

48

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

T-helper (1) cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion

49

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Activation of NK cell cytotoxicity

50

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells

51

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells

52

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

53

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

54

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

55

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways

56

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation

57

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.

58

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Modulation of the surface expression of CD158 killer cell Ig-like receptor by interleukin-2 and transforming growth factor-beta

59

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors

60

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Effect of interleukin 2 on killer cell inhibitory receptors in patients with rheumatoid arthritis

61

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Interferon--a major regulator of natural killer cell-mediated cytotoxicity

62

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy.

63

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells

64

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha

65

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

IFNalpha regulates NK cell cytotoxicity through STAT1 pathway

66

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Impaired interferon signaling is a common immune defect in human cancer

67

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Activities of IRF-1

68

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

IFN-alpha and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells

69

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Dendritic cell interactions with NK cells from different tissues

70

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Distribution of several activating and inhibitory receptors on CD3-CD16+ NK cells and their correlation with NK cell function in healthy individuals.

71

1 reference

10.1016/J.BIOPHA.2010.06.013

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.06.013

3 July 2024

Identifiers

10.1016/J.BIOPHA.2010.06.013

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39662490&oldid=2194228341"